The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...

GSK is investing up to $800 million to double the size and capacity of its production site in Marietta, Pennsylvania, the company said Thursday. Through the addition of two new facilities ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

GSK is setting aside a mid-stage 24-valent pneumococcal vaccine program for adults to instead focus on a preclinical option that covers 30-plus valents, the company announced Wednesday alongside its ...

GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...

GSK (GSK) plc announced what it calls its ... manufacturing capabilities to the company’s site in Marietta, Pennsylvania, along with over 200 new jobs, the company stated.

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, ...

MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...

The FTSE 100 closed down 59.98 points at 8159.63 as traders digest Chancellor Rachel Reeves's Budget today. Among the ...

Pennsylvania, creating around 200 new jobs. The centrepiece of the new investment is a multi-purpose facility capable of manufacturing sterile liquid vaccines and medicines, for which GSK says ...